[{"NetIncomeLoss_1_Q1_USD":-12582000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":47699.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":3367000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":210000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":25531000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":6951000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":835000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":3775000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":194000.0,"NumberOfReportingUnits_1_Q1_Segment":1.0,"CommonStockSharesIssued_0_Q1_shares":47712636.0,"Assets_0_Q1_USD":78117000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":210000.0,"ShareBasedCompensation_1_Q1_USD":1236000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":194000.0,"AvailableForSaleSecurities_0_Q1_USD":39487000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":2.75,"PreferredStockSharesOutstanding_0_Q1_shares":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":7.16,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":1302000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.72,"IncomeTaxExpenseBenefit_1_Q1_USD":null,"CommonStockValue_0_Q1_USD":5000.0,"AvailableForSaleSecuritiesAndHeldToMaturitySecurities_0_Q1_USD":39500000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAociForInvestmentTransferredFromAvailableForSaleToEquityMethodAfterTax_1_Q1_USD":null,"MarketableSecuritiesCurrent_0_Q1_USD":39487000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":null,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":16000000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-12372000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":1761000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0131,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":37142000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":210000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q1_USD":39277000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":194000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":9090000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1_Q1_USD":210000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"CommonStockSharesOutstanding_0_Q1_shares":47712636.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":9049000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_1_Q1_USD":21000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-12582000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-9168000.0,"LiabilitiesCurrent_0_Q1_USD":6903000.0,"AccountsPayableCurrent_0_Q1_USD":3536000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-2023000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":1488000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":184000.0,"AdditionalPaidInCapital_0_Q1_USD":162642000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q1_USD":39500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":37142000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":55000.0,"PreferredStockSharesIssued_0_Q1_shares":null,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":13001000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":194000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":865000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-91643000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":6674000.0,"OperatingIncomeLoss_1_Q1_USD":-12865000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":309000.0,"InvestmentIncomeInterest_1_Q1_USD":283000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":210000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":12.8,"PreferredStockValue_0_Q1_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":2012000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":3.57,"PreferredStockSharesAuthorized_0_Q1_shares":25000000.0,"SharePrice_0_Q1_USD":12.8,"OperatingExpenses_1_Q1_USD":12865000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.26,"ProfitLoss_1_Q1_USD":-12582000.0,"StockholdersEquity_0_Q1_USD":71214000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-1000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":78117000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":220000.0,"Ticker":"PRVB","CIK":"1695357","name":"PROVENTION BIO, INC.","OfficialName":"Provention Bio Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"371519921.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]